NCT02148185View on ClinicalTrials.gov

Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Crohn's Disease
Interventions
DRUG

MT-1303

Trial Locations (2)

Unknown

Inverstigational site, Chūbu

Inverstigational site, Kanto

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY